Armotraz (Anastrozole)

Armotraz (Anastrozole) – Comprehensive Patient Guide for Australia

Basic Product Information

Mechanism of Action

In simple terms: Anastrozole belongs to a group of medicines called aromatase inhibitors. It works by lowering the amount of oestrogen (a type of female hormone) in your body. Many breast cancers grow faster when they are exposed to oestrogen. By reducing oestrogen production, Armotraz helps to slow or stop the growth of these cancers.

Specialist's summary: Anastrozole selectively inhibits the aromatase enzyme, which catalyses the final step of oestrogen biosynthesis. This action drastically reduces serum oestrogen levels in postmenopausal women, thereby lowering the stimulation of oestrogen receptor-positive breast cancer cells.

Pharmacokinetics

• Absorption: Well absorbed orally; peak plasma concentration within 2 hours of dosing.
• Bioavailability: Approx. 83–85%; unaffected by foods.
• Metabolism: Liver (mainly via N-dealkylation, hydroxylation, and glucuronidation).
• Elimination Half-life: 40–50 hours (steady state within 7 days).
• Excretion: Primarily urine (as metabolites and unchanged drug).
• Duration of Action: Continuous oestrogen suppression with daily dosing.

Use in Everyday Life and Best Practices

Armotraz (Anastrozole) is most often prescribed for women after menopause diagnosed with oestrogen receptor-positive early or advanced breast cancer. It is sometimes offered as an adjuvant therapy to reduce recurrence or after initial therapy to maintain remission.

• Typical Adult Dose: 1 mg once daily, at the same time each day.
• How to Take: Swallow the tablet whole with a full glass of water. Do not crush, chew, or split the tablet.
• Duration: Your specialist will tell you how long to take it. Treatment may last for several years (typically 5 years), depending on your cancer type and risk profile.
• Storage: Store below 25°C. Keep tablets in the original packaging until use.
• Missed dose: Take as soon as you remember unless it’s close to your next scheduled dose. Never double-up doses.

Discuss your medicine schedule with your pharmacist or nurse, especially if you take other regular medications or have other health concerns.

Dosing in the Morning vs Evening

• Morning: Many patients find it easier to remember taking their dose with breakfast, helping to create a regular habit.
• Evening: Some prefer the evening to minimise possible daytime side effects, such as fatigue or joint stiffness.
• Best Practice: Take Armotraz at the time of day that suits you best, and stick to it every day. Consistency helps maintain stable levels in your body.

Talk to your pharmacist or doctor if you notice particular side effects at one time of day—they may recommend taking your tablet at a different time.

Taking with Food or on an Empty Stomach

Armotraz can be taken with or without food. Food does not significantly change how much medicine your body absorbs. In the English context, the medicine may be taken with a light breakfast or dinner, or in between meals, depending on personal preference.

• Avoid taking the tablet with grapefruit or grapefruit juice, as it might affect medicine metabolism.
• Drink enough water and maintain a balanced diet (protein, fibre, fruits, and vegetables) to help manage possible side effects such as bone loss and joint symptoms.

Interaction Warnings

Indications

Dosing According to Clinical Indication

Safety Profile & Side Effects

Guidelines for Proper Use (Practical Advice for Australia)

• Have regular follow-up visits with your oncologist/GP, including blood tests and bone density scans as recommended.
• Tell your doctor about all medicines and supplements you are taking.
• Get enough calcium and vitamin D; discuss supplementation if needed, especially if you are at risk of osteoporosis.
• Physical activity, such as walking or swimming, helps bone and joint health.
• Do not share your medicine with others, even if they have similar symptoms.
• Keep medicines out of reach of children.
• Use the Pharmaceutical Benefits Scheme (PBS) and My Health Record for subsidised, coordinated care.
• Contact your pharmacist for advice on side effects, interactions, or travel with medicine.

Alternative Treatment Options (PBS-Listed in Australia)

• Tamoxifen: Effective in hormone receptor-positive breast cancer. Suitable for both pre- and postmenopausal women; higher risk of blood clots and endometrial effects.
• Letrozole: Another aromatase inhibitor with similar indications and side effect profile; consider if patients are intolerant to anastrozole.
• Exemestane: Steroidal aromatase inhibitor; alternative if side effects develop on first-line options.
• Ovarian ablation or suppression (in premenopausal women): Used in specialised cases, often together with other medications.

Pros/Cons: The choice depends on menopausal status, prior therapy, risk of osteoporosis, and side effect tolerance. Discuss options with your oncologist or breast care nurse.

Legal, Registration, and Reimbursement Status in Australia

• Legal status: Prescription required (S4). Only available through a registered Australian pharmacy with a valid prescription.
• Registration: Approved by the Therapeutic Goods Administration (TGA).
• Subsidy: Listed on the Pharmaceutical Benefits Scheme (PBS) for indicated cancers—subsidised for eligible patients. Not reimbursed for off-label uses.
• Record keeping: Prescriptions and usage will be recorded as per My Health Record and TGA guidelines.

Latest Research and Clinical Guidance (2022–2025)

• Current (2024) National Breast Cancer Foundation and Cancer Australia guidance ranks anastrozole as first-line endocrine therapy for postmenopausal women with hormone receptor–positive breast cancer.
• Latest studies confirm efficacy and safety for up to 10 years of use, especially in high-risk recurrence groups. See Howell et al (Lancet 2022), Francis et al (NEJM 2023).
• Emphasis on bone health: Regular monitoring and preventative strategies recommended by The Royal Australian College of General Practitioners (RACGP).
• Routine genetic and molecular profiling of tumours increasingly guides therapy adjustments.

Availability and Delivery

Frequently Asked Questions (FAQ)

1. Is it safe to take Armotraz (Anastrozole) long-term?

Yes. Many patients safely use anastrozole for 5–10 years. Your doctor will monitor you for side effects, especially bone health, cholesterol changes, and liver function.

2. Can I continue my usual diet and exercise while on Armotraz?

Generally yes, but ensure you maintain adequate calcium, vitamin D, and undertake regular weight-bearing exercise to support your bones. Consult your GP or dietitian for individual advice.

3. What should I do if I miss a dose?

Take the missed dose as soon as you remember—but if it’s nearly time for the next dose, just skip the missed one. Do not double the dose to catch up.

4. Are there any medicines or supplements I should avoid?

Avoid oestrogen-containing products and always check with your pharmacist or doctor before starting any new medicine or supplement, including herbal products.

5. Can I drink alcohol while taking Armotraz?

Small social amounts are likely safe, but frequent or heavy drinking increases your risk of side effects and interacts negatively with cancer treatment. If you have liver concerns, check with your specialist.